Hybrid Sensor-based Physiological Control of an Implantable Rotary Blood Pump

全世界有超过1100万人需要心脏移植，而只有3000个供体心脏，因此需要一种有效的替代疗法。Ventracor Ltd.旋转血泵是一种可能的方法，通过这种方法，完全植入的机械装置辅助衰竭的心脏。这项研究提案中的创新步骤将是一种稳健和安全地控制泵速度以满足身体代谢需求的手段。除了为患者带来明显的健康益处外，这将为该公司提供巨大的市场优势，也将有助于支持澳大利亚医疗器械行业。

With over 11 million people needing heart transplants worldwide and only 3000 donor hearts, an effective alternative therapy is needed. The Ventracor Ltd. rotary blood pump is one possible approach whereby a fully implantable mechanical device assists the failing heart. The innovative steps in this research proposal will be a means to robustly and safely control the speed of the pump to meet the metabolic needs of the body. Apart from the obvious health benefits for patients, this will provide the company with a huge market advantage that will also help to bolster the Australian medical device industry.